Performance of the Cepheid Methicillin-Resistant Staphylococcus aureus/S. aureus Skin and Soft Tissue Infection PCR Assay on Respiratory Samples from Mechanically Ventilated Patients for S. aureus Screening during the Phase 2 Double-Blind SAATELLITE Study
Alexey Ruzin(AstraZeneca (United States)), Mark T. Esser(AstraZeneca (United States)), Drieke Vandamme(Inserm), Herman Goossens(Kaneka (United States)), Li Yu(Hangzhou Medical College), Miguel Sánchez García(Hospital Clínico San Carlos), Terramika Bellamy(AstraZeneca (United States)), Cédric Bretonnière(Inserm), Christine Lammens(Antwerp University Hospital), L. Viña(Hospital Universitario Central de Asturias), Olivier Barraud(Inserm), Pierre‐François Laterre(Cliniques Universitaires Saint-Luc), Bret R. Sellman(AstraZeneca (United States)), Jérôme Pugin(University Hospital of Geneva), Michael McCarthy(AstraZeneca (United States)), Pin Ren(AstraZeneca (United States)), Kathryn Shoemaker(AstraZeneca (United States)), Ana Catalina Hernandez Padilla(Inserm), Hasan S. Jafri(AstraZeneca (Australia)), Susan Colbert(AstraZeneca (United States)), Philippe Eggimann(University Hospital of Lausanne), Pierre‐François Dequin(Université de Tours), Omar Ali(AstraZeneca (United States)), Bruno François(Inserm), Josep Trenado(Mútua Terrassa), Thierry Boulain(Centre hospitalier universitaire d'Orléans), Julie Vignaud(Inserm), Vincent Huberlant(Centre Hospitalier Universitaire de Nantes)
Cited by 11
Related Papers
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
|New England Journal of Medicine|2001|6.1k
Global increase and geographic convergence in antibiotic consumption between 2000 and 2015
|Proceedings of the National Academy of Sciences|2018|3.2k
High-Flow Oxygen through Nasal Cannula in Acute Hypoxemic Respiratory Failure
|New England Journal of Medicine|2015|2.4k
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19
|JAMA|2020|2.4k
Assessment of the worldwide burden of critical illness: the Intensive Care Over Nations (ICON) audit
|The Lancet Respiratory Medicine|2014|1.3k